Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction

Circulation

Volumn 106, Issue 23, 2002, Pages 2961-2966

  Weinberg, Ellen O ^a   Shimpo, Masahisa ^a   De Keulenaer, Gilles W ^a   MacGillivray, Catherine ^a   Tominaga, Shin ichi ^a,b   Solomon, Scott D ^a   Rouleau, Jean Lucien ^a,c   Lee, Richard T ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Creatine kinase; Infarction; Interleukins; Receptors; Stress

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; HYDROGEN PEROXIDE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ST2; INTERLEUKIN 1BETA; INTERLEUKIN 4; MESSENGER RNA; TIRON; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; RAT; TRANSCRIPTION INITIATION;

NON-PROGRAMMATIC;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; IMIDAZOLES; INTERLEUKIN-1; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; NUCLEASE PROTECTION ASSAYS; PHORBOL ESTERS; PROMOTER REGIONS (GENETICS); PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN-1; RNA, MESSENGER; STRESS, MECHANICAL; STROKE VOLUME;

EID: 0037016036     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000038705.69871.D9     Document Type: Article

References (32)

1. Iwahana H, Yanagisawa K, Ito-Kosaka A, et al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur J Biochem. 1999;264:397-406.
2. Bergers G, Reikerstorfer A, Braselmann S, et al. Alternative promoter usage of the fos-responsive gene Fit-1 generates RNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 1994;13:1176-1188.
3. Tominaga S. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin-1 receptor. FEBS Lett. 1989;258:301-304.
4. Lohning M, Stroehmann A, Coyle AJ, et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci U S A. 1998;95:6930-6935.
5. Coyle AJ, Lloyd C, Tian J, et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med. 1999;190:895-902.
6. Prechtel D, Harbeck N, Berger U, et al. Clinical relevance of T1-S, an oncogene-inducible, secreted glycoprotein of the immunoglobulin superfamily, in node-negative breast cancer. Lab Invest. 2001;81:159-165.
7. Kumar S, Minnich MD, Young PR. ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1. J Biol Chem. 1995;270:27905-27913.
8. Gayle MA, Slack JL, Bonnert TP, et al. Cloning of a putative ligand for the T1/ST2 receptor. J Biol Chem. 1996;271:5784-5789.
9. Dale M, Nicklin MJH. Interleukin-1 receptor cluster: Gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1/ST2), and IL18R1(IL-1Rrp) on human chromosome 2q. Genomics. 1999;57:177-179.
10. Yamamoto K, Dang QN, Kennedy SP, et al. Induction of tenascin-C in cardiac myocytes by mechanical deformation. J Biol Chem. 1999;274:21840-21846.
11. Feldman AM, Weinberg EO, Ray PE, et al. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 1993;73:184-192.
12. Rohde LE, Ducharme A, Arroyo LH, et al. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation. 1999;23:3063-3070.
13. Pfeffer MA, Greaves SC, Arnold MO, et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. Circulation. 1997;95:2643-2651.
14. Solomon SD, Glynn RJ, Greaves S, et al. Recovery of ventricular function after myocardial infarction in the reperfusion era: The healing and early afterload reducing therapy study. Ann Intern Med. 2001;134:451-458.
15. Aikawa Y, Rohde L, Plehn J, et al. Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): An echocardiography-based structural analysis. Am Heart J. 2001;141:234-242.
16. Kuroiwa K, Li H, Tago K, et al. Construction of ELISA system to quantify human ST2 protein in sera of patients. Hybridoma. 2000;19:151-159.
17. Takagi T, Yanagisawa K, Tsukamoto T, et al. Identification of the product of the murine ST2 gene. Biochim Biophys Acta. 1993;1178:194-200.
18. Sadoshima J, Xu Y, Slayter HS, et al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;5:977-984.
19. Carter RW, Sweet MJ, Xu D, et al. Regulation of ST2L expression on T helper (Th) type 2 cells. Eur J Immunol. 2001;31:2979-2985.
20. Gachter T, Werenskiold AK, Klemenz R. Transcription of the interleukin-1 receptor-related T1 gene is initiated at different promoters in mast cells and fibroblasts. J Biol Chem. 1996;271:124-129.
21. Born TL, Smith DE, Garka KE, et al. Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. J Biol Chem. 2000;275:29946-29954.
22. Reikerstorfer A, Holz H, Stunnenberg HG, et al. Low affinity binding of interleukin-1 β and intracellular signaling via NF-κB identify Fit-1 as a distant member of the interleukin-1 receptor family. J Biol Chem. 1995;270:17645-17648.
23. Mitcham JL, Parnett P, Bonnert TP, et al. T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J Biol Chem. 1996;271:5777-5783.
24. Mann DL, Stress activated cytokines and the heart. Cytokine Growth Factor Rev. 1996;7:341-354.
25. St John Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: Pathophysiology and therapy. Circulation. 2000;101:2981-2988.
26. O'Neill LAJ, Dinarello CA. The IL-1 receptor/toll-like receptor super-family: Crucial receptors for inflammation and host defense. Immunol Today. 2000;21:206-209.
27. Xu D, Chan WL, Leung BP, et al. Selective expression of a stable cell surface molecule on type 2 but not type I helper T cells. J Exp Med. 1998;187:787-794.
28. Yamaoka M, Yamaguchi S, Okuyama M, et al. Anti-inflammatory cytokine profile in human heart failure: Behaviour of interleukin-10 in association with tumor necrosis factor-α. Jpn Circ J. 1999;63:951-954.
29. Ohtsuka T, Hamada M, Hiasa G, et al. Effect of β-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2001;37:412-417.
30. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: Endogenous activators of dendritic cells. Nat Med. 1999;5:1249-1255.
31. Delves PJ, Roitt IM. The immune system. New Engl J Med. 2000;343:37-49.
32. More SH, Breloer M, von Bonin A. Eukaryotic heat shock proteins as molecular links in innate and adaptive immune responses: Hsp60-mediated activation of cytotoxic T cells. Int Immunol. 2001;13:1121-1127.